Shares of Bio-Reference Laboratories Inc (NASDAQ: BRLI) are skyrocketing in Thursday’s pre-market session, up more than 41 percent. The catalyst for the rally is due to a signing of a definitive ...

A Florida biopharmaceutical and diagnostics company is paying nearly $1.5 billion in stock for Elmwood Park-based diagnostics laboratory firm Bio-Reference Laboratories Inc.OPKO Health Inc. said ...

ELMWOOD PARK, N.J., Oct. 10, 2012 /PRNewswire/ -- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) today officially announced the launch of Laboratorio Buena Salud (www.LaboratorioBuenaSalud.com), the ...

Bio-Reference Laboratories, Inc. provides clinical laboratory testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. It offers a ...

When it comes to the healthcare sector, the Justice Department and the HHS-Office of Inspector General have no shortage of investigations and targets for prosecution. The more resources made available ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million for ...

Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...

Feel free to take Bio-Reference ( BRLI ) at its word yet again. That's fine; hold onto that stock, regardless of its vulnerabilities. At least try to arrive at an informed decision, however, by ...